Salicin inhibits AGE-induced degradation of type II collagen and aggrecan in human SW1353 chondrocytes: therapeutic potential in osteoarthritis

References

• Zhang Y, Liu YB, Li Y, et al. Sesquiterpenes and alkaloids from the roots of Alangium chinense. J Nat Prod. 2013;76:1058–1063.
   PubMed Web of Science ®Google Scholar
• Gong NB, Du LD, Lu Y. Anabasine. In Natural small molecule drugs from plants. Singapore: Springer; 2018. p. 353–356.
   Google Scholar
• Lin C, Cai J, Xu Y, et al. Effect of Alangium chinense on CYP450 isoforms activity of rats. Int J Clin Exp Med. 2016;9:3097–3103.
   Web of Science ®Google Scholar
• Aboelsoud N. Herbal medicine in ancient Egypt. J Med Plants Res. 2010;4:82–86.
   Google Scholar
• Duan H, Zhai KF, Gao GZ, et al. Macroporous resin adsorption for purification of salicin from Alangium chinense (Lour.) Harms. Food Sci. 2012;33:99–102.
   Google Scholar
• Chen F, Mo K, Liu Z, et al. Ionic liquid-based vacuum microwave-assisted extraction followed by macroporous resin enrichment for the separation of the three glycosides salicin, hyperin and rutin from Populus bark. Molecules 2014; 19:9689–9711.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu YB, Li Y, et al. Terpenoids from the roots of Alangium chinense. J Asian Nat Prod Res. 2015;17:1025–1038.
   PubMed Web of Science ®Google Scholar
• Zabihi NA, Mahmoudabady M, Soukhtanloo M, et al. Salix alba attenuated oxidative stress in the heart and kidney of hypercholesterolemic rabbits. Avicenna J Phytomed. 2018;8:63.
   PubMed Web of Science ®Google Scholar
• Schmid B, Kötter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol. 2001;57:387–391.
   PubMed Web of Science ®Google Scholar
• Klessig DF, Tian M, Choi HW. Multiple targets of salicylic acid and its derivatives in plants and animals. Front Immunol. 2016;7:206.
   PubMed Web of Science ®Google Scholar
• Verzijl N, DeGroot J, Zaken CB, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002;46:114–123.
   PubMed Web of Science ®Google Scholar
• Qu H, Li J, Wu L, et al. Trichostatin A increases the TIMP-1/MMP ratio to protect against osteoarthritis in an animal model of the disease. Mol Med Rep.2016;14:2423–2430.
   PubMed Web of Science ®Google Scholar
• P. Garnero. Chapter 8 – biochemical markers of osteoarthritis. In Sharma L, Berenbaum F. Osteoarthritis. Mosby; 2007. p. 113–130.
   Google Scholar
• Nah SS, Choi IY, Yoo B, et al. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-alpha in human osteoarthritic chondrocytes. FEBS Lett. 2007;581:1928–1932.
   PubMed Web of Science ®Google Scholar
• Verma P, Dalal K. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem. 2011;112:3507–3514.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Giustarini D, Colombo R, et al. Protein carbonylation in human diseases. Trends Mol Med. 2003;9:169–176.
   PubMed Web of Science ®Google Scholar
• Liu X, Fang H, Zeng C, et al. Myricetin attenuates osteoarthritis by blockade of the IL-1β/MAPK pathway. Osteoarthritis Cartilage. 2018;26:S84.
   PubMed Web of Science ®Google Scholar
• Xu YK, Ke Y, Wang B, et al. The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis. Biol Res. 2015;48:64.
   PubMed Web of Science ®Google Scholar
• Amin AR, Islam AB. Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1. DNA Cell Biol. 2014;33:550–565.
   PubMed Web of Science ®Google Scholar
• Yang HP, Lundbäck P, Ottoson L, et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med. 2012;18:250–259.
   PubMed Web of Science ®Google Scholar
• Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012;8:195–202.
   PubMed Web of Science ®Google Scholar
• Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862:576–591.
   PubMed Web of Science ®Google Scholar
• Ahmadinejad F, Geir Møller S, Hashemzadeh-Chaleshtori M, et al. Molecular mechanisms behind free radical scavengers function against oxidative stress. Antioxidants. 2017;6:51.
   Web of Science ®Google Scholar
• Dalle-Donne I, Aldini G, Carini M, et al. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med. 2006;10:389–406.
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33.
   PubMed Web of Science ®Google Scholar
• Wang J, Markova D, Anderson DG, et al. TNF-α and IL-1β promote a disintegrin-like and metalloprotease with thrombospondin type I motifs (ADAMTS)-5 mediated aggrecan degradation through syndecan-4 in intervertebral disc. J Biol Chem. 2011;286:39738–39749.
   Web of Science ®Google Scholar
• Roman-Blas JA, Jimenez SA. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2006;14:839–848.
   PubMed Web of Science ®Google Scholar
• Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta. 2007;375:36–42.
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008;10:209.
   PubMed Web of Science ®Google Scholar
• Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23:471–478.
   PubMed Web of Science ®Google Scholar
• Roshak AK, Callahan JF, Blake SM. Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease. Curr Opin Pharmacol. 2002;2:316–321.
   PubMed Web of Science ®Google Scholar
• Rigoglou S, Papavassiliou AG. The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013;45:2580–2584.
   PubMed Web of Science ®Google Scholar